ArticleMaedica2020
A Review on Aorta Mesenteric Bypass in Surgical Management of Mesenteric Ischemia: Indications, Techniques and Outcomes.
Article in Maedica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
- Acute mesenteric ischaemia in the elderly - results of combined endovascular and surgical treatment. Primary study.Scientific reports · 2025Article
- Axillary to Superior Mesenteric Artery Bypass as a Viable Solution for Chronic Mesenteric Ischemia.Cureus · 2024Article
- miR-124 promotes apoptosis and inhibits the proliferation of vessel endothelial cells through P38/MAPK and PI3K/AKT pathways, making it a potential mechanism of vessel endothelial injury in acute myocardial infarction.Experimental and therapeutic medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenteric ischemia (MI) is a rare medical condition which involves insufficient blood supply, inflammatory injury and eventually bowel wall necrosis with high mortality rates. Acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI) are the two major types of mesenteric ischemia. Therapeutic approach of MI includes medical as well as surgical treatment. This review article aims to delineate the abreast knowledge on indications, management through mesenteric bypass surgical technique, and clinical outcomes. Clinical presentation of AMI and CMI varies substantially, depending on the etiology underlying it. The most common symptom of AMI is abdominal pain that is disproportionate to the outcomes of physical exams; whereas CMI normally induces postprandial abdominal pain, commonly epigastric or periumbilical, nausea and weight loss. Recent awareness of AMI management revealed that exploratory laparotomy surgical procedure with careful evaluation of bowel viability played a pivotal role in restoring intestinal oxygenation and avoiding serious complications such as peritonitis and perforation of the gangrene bowels. The management of CMI is mainly surgical, with Aorta/Iliac-SMA bypass and Aorta-Splenic bypass being the currently available options. Due to the high thrombosis levels, only patients whose surgical risk outweighs possible benefits are required for medical care as a single treatment. Furthermore, this review also postulates that aorto mesenteric revascularization procedures for chronic mesenteric ischemia are feasible, but involve careful selection of patients, and they should only be performed by vascular surgeons with extensive experience in laparoscopic vascular surgery at referral centers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.